The following post was published on the Knowledge@Wharton website on July 31, 2013. When it comes to executing strategy, the old saying "the devil is in the details" holds true for many companies, ...

To make sense of the growing attention to strategy execution, we first need to understand what this trend looks like—and whether it is actually a trend, a temporary peak, or something else. Since we ...

When it comes to executing strategy, the old saying "the devil is in the details" holds true for many companies, according to Wharton emeritus management professor Lawrence G. Hrebiniak. While ...

My department is great at planning, but bad at executing our plans. We seem to let the plans rest on the shelf with little implementation of the strategies we worked so hard to prepare. What is ...

Strategies are shaped by the processes that produce them. If designed well, a strategy formulation process enables decisionmakers to evaluate the political, security, and budgetary environments, ...

ATLANTA, March 4, 2025 /PRNewswire/ -- AchieveIt, a leading provider of strategy execution and performance management solutions, has released the findings of its first-ever State of Strategy Execution ...

DUBLIN--(BUSINESS WIRE)--The "Strategic Thinking and Strategy Formulation" training has been added to ResearchAndMarkets.com's offering. The Strategic Thinking and Strategy Formulation 3-day workshop ...

Opinions expressed by Entrepreneur contributors are their own. Every year millions of entrepreneurs come up with great ideas. And every year they spend countless hours creating and re-creating ...

In March, we surveyed members of the HBR Advisory Council (a representative group of readers we periodically turn to for insights) about strategy and execution in their organizations. We asked how ...

The oil industry holds relatively few surprises for strategists. Things change, of course, sometimes dramatically, but in relatively predictable ways. Planners know, for instance, that global supply ...

A dearth of new molecules and impending patent cliffs have turned drug-delivery technologies into a hotbed for innovation, with companies desperate to gain an edge over rivals, says Lux Research.